Miller Lab
@MillerLabNeuro
Followers
725
Following
336
Statuses
168
Tim Miller lab | Washington University School of Medicine | Translational ALS and Alzheimer's disease research
St Louis, MO
Joined April 2019
Dr. Tim Miller (@TimMillerNeuro @WashUNeurology) recently shared new Phase 3 #tofersen results at ENCALS 2022. Check out the full dataset here:
On behalf of The VALOR and OLE Working Group, Timothy Miller presented new 12 month data for Tofersen at the recent ENCALS 2022 meeting.
0
1
11
RT @wade_self: I am honored to be a part of @NIHprevents' next #PreventionInFocus webinar on October 10 at 2:00 p.m. ET, to discuss the pro…
0
4
0
We're breaking our posting silence to congratulate Miller Lab graduate student @MiweiHu on her excellent poster presentation at the @RCFNeuro Tau Consortium last week. Miwei discussed the effects of #tau splicing on #sleep in #tauopathy. Keep up the great work!
0
1
8
Cool work coming out of @adrianisaacslab from former Miller Lab graduate student @AlexCammack. Can’t wait to dive into the data!
Really excited about our latest preprint, where we uncovered a neuroprotective role for neuronal polyunsaturated fatty acids in FTD and ALS. Led by @AshlingGiblin and @AlexCammack 1/9
0
1
5
Thank you @MtlSyndrome for your generous support! We look forward to working with you on this exciting project to develop a potential treatment for Mitchell Syndrome!
0
0
1
Huge congratulations to Dr. Miller on being elected to the National Academy of Medicine! We’re lucky to have you at the helm!
Congratulations to our three #WashUMed faculty members elected to the National Academy of Medicine: Michael S. Avidan, MBBCh, Sarah K. England, PhD, and Timothy Miller, MD, PhD. Learn more about their groundbreaking work here:
0
3
24
Congratulations, Alex! We look forward to seeing more of your exciting and important work!
I’m really excited to announce I’ve received a Postdoctoral Fellowship Award from the @LiveLikeLou4 organization to support our work investigating the role of lipids in #ALS! I’m grateful for this opportunity and look forward to continuing our studies on this devastating disease.
0
0
3
.@TimMillerNeuro This Is Your Life! Happy to host a virtual reunion of Miller Lab alumni to celebrate the FDA approval of #tofersen for SOD1 #ALS. Congrats to Tim and everyone involved!
0
2
27
RT @ALSCenterWashU: New SOD1 #ALS drug candidate, #tofersen, is up for review by an FDA Advisory Committee on Wednesday, March 22nd from 9:…
0
3
0
5. More studies and randomized controlled trials in humans will be needed to understand the potential neuroprotective benefit of #lovastatin to ALS patients.
0
0
1
Exciting news! Well deserved honor for @TimMillerNeuro and colleagues!
Please join us in congratulating our 2023 winners of the Rainwater Prize for Outstanding Innovation in Neurodegenerative Disease Research and the Rainwater Prize for Innovative Early-Career Scientist. Click to read about recipients! #rainwaterprize
1
0
18
RT @DrMayl: Read our latest paper out in @NatureComms on genotype-phenotype correlations in SOD1-#ALS. This is the largest study of its kin…
0
6
0
RT @ALSCenterWashU: Delighted to share a major step forward in treating #ALS. Published results for ASO therapy #Tofersen for #SOD1 ALS htt…
0
24
0